219 related articles for article (PubMed ID: 24235827)
1. Fate of paclitaxel lipid nanocapsules in intestinal mucus in view of their oral delivery.
Groo AC; Saulnier P; Gimel JC; Gravier J; Ailhas C; Benoit JP; Lagarce F
Int J Nanomedicine; 2013; 8():4291-302. PubMed ID: 24235827
[TBL] [Abstract][Full Text] [Related]
2. Development of 2D and 3D mucus models and their interactions with mucus-penetrating paclitaxel-loaded lipid nanocapsules.
Groo AC; Mircheva K; Bejaud J; Ailhas C; Panaiotov I; Saulnier P; Ivanova T; Lagarce F
Pharm Res; 2014 Jul; 31(7):1753-65. PubMed ID: 24469905
[TBL] [Abstract][Full Text] [Related]
3. Lipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosis.
Roger E; Lagarce F; Garcion E; Benoit JP
J Control Release; 2009 Dec; 140(2):174-81. PubMed ID: 19699246
[TBL] [Abstract][Full Text] [Related]
4. Reciprocal competition between lipid nanocapsules and P-gp for paclitaxel transport across Caco-2 cells.
Roger E; Lagarce F; Garcion E; Benoit JP
Eur J Pharm Sci; 2010 Aug; 40(5):422-9. PubMed ID: 20438839
[TBL] [Abstract][Full Text] [Related]
5. Mucus penetrating properties of soft, distensible lipid nanocapsules.
Chen H; Mansfield EDH; Woods A; Khutoryanskiy VV; Forbes B; Jones SA
Eur J Pharm Biopharm; 2019 Jun; 139():76-84. PubMed ID: 30818012
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of cellular uptake and cytotoxicity of paclitaxel loaded lipid nanocapsules in breast cancer cells.
Valsalakumari R; Yadava SK; Szwed M; Pandya AD; Mælandsmo GM; Torgersen ML; Iversen TG; Skotland T; Sandvig K; Giri J
Int J Pharm; 2021 Mar; 597():120217. PubMed ID: 33486035
[TBL] [Abstract][Full Text] [Related]
7. Lipid nanocapsules: ready-to-use nanovectors for the aerosol delivery of paclitaxel.
Hureaux J; Lagarce F; Gagnadoux F; Vecellio L; Clavreul A; Roger E; Kempf M; Racineux JL; Diot P; Benoit JP; Urban T
Eur J Pharm Biopharm; 2009 Oct; 73(2):239-46. PubMed ID: 19560538
[TBL] [Abstract][Full Text] [Related]
8. Development of multifunctional lipid nanocapsules for the co-delivery of paclitaxel and CpG-ODN in the treatment of glioblastoma.
Lollo G; Vincent M; Ullio-Gamboa G; Lemaire L; Franconi F; Couez D; Benoit JP
Int J Pharm; 2015 Nov; 495(2):972-80. PubMed ID: 26428632
[TBL] [Abstract][Full Text] [Related]
9. Absence of lung fibrosis after a single pulmonary delivery of lipid nanocapsules in rats.
Hureaux J; Lacoeuille F; Lagarce F; Rousselet MC; Contini A; Saulnier P; Benoit JP; Urban T
Int J Nanomedicine; 2017; 12():8159-8170. PubMed ID: 29184405
[TBL] [Abstract][Full Text] [Related]
10. Lipid- and TPGS-Based Core-Shell-Type Nanocapsules Endowed with High Paclitaxel Loading and Enhanced Anticancer Potential.
Katiyar SS; Patil R; Ghadi R; Kuche K; Kushwah V; Dora CP; Jain S
AAPS PharmSciTech; 2022 Aug; 23(7):238. PubMed ID: 36002600
[TBL] [Abstract][Full Text] [Related]
11. In vivo evaluation of paclitaxel-loaded lipid nanocapsules after intravenous and oral administration on resistant tumor.
Groo AC; Bossiere M; Trichard L; Legras P; Benoit JP; Lagarce F
Nanomedicine (Lond); 2015 Mar; 10(4):589-601. PubMed ID: 25723092
[TBL] [Abstract][Full Text] [Related]
12. Lipid nanocapsules co-encapsulating paclitaxel and salinomycin for eradicating breast cancer and cancer stem cells.
Basu SM; Yadava SK; Singh R; Giri J
Colloids Surf B Biointerfaces; 2021 Aug; 204():111775. PubMed ID: 33940518
[TBL] [Abstract][Full Text] [Related]
13. Conventional versus stealth lipid nanoparticles: formulation and in vivo fate prediction through FRET monitoring.
Lainé AL; Gravier J; Henry M; Sancey L; Béjaud J; Pancani E; Wiber M; Texier I; Coll JL; Benoit JP; Passirani C
J Control Release; 2014 Aug; 188():1-8. PubMed ID: 24878182
[TBL] [Abstract][Full Text] [Related]
14. The gastrointestinal stability of lipid nanocapsules.
Roger E; Lagarce F; Benoit JP
Int J Pharm; 2009 Sep; 379(2):260-5. PubMed ID: 19524655
[TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of tetrandrine-phospholipid complex loaded lipid nanocapsules as potential oral carriers.
Zhao YQ; Wang LP; Ma C; Zhao K; Liu Y; Feng NP
Int J Nanomedicine; 2013; 8():4169-81. PubMed ID: 24204145
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of intact lipid nanocapsules using new quantitative FRET technique.
Lebreton V; Kaeokhamloed N; Vasylaki A; Hilairet G; Mellinger A; Béjaud J; Saulnier P; Lagarce F; Gattacceca F; Legeay S; Roger E
J Control Release; 2022 Nov; 351():681-691. PubMed ID: 36191672
[TBL] [Abstract][Full Text] [Related]
17. Supramolecular micellar nanoaggregates based on a novel chitosan/vitamin E succinate copolymer for paclitaxel selective delivery.
Lian H; Sun J; Yu YP; Liu YH; Cao W; Wang YJ; Sun YH; Wang SL; He ZG
Int J Nanomedicine; 2011; 6():3323-34. PubMed ID: 22228999
[TBL] [Abstract][Full Text] [Related]
18. Mucus adhesion- and penetration-enhanced liposomes for paclitaxel oral delivery.
Liu Y; Yang T; Wei S; Zhou C; Lan Y; Cao A; Yang J; Wang W
Int J Pharm; 2018 Feb; 537(1-2):245-256. PubMed ID: 29288808
[TBL] [Abstract][Full Text] [Related]
19. Lipid nanocapsules as a new delivery system in copepods: Toxicity studies and optical imaging.
Stancheva S; Souissi A; Ibrahim A; Barras A; Spriet C; Souissi S; Boukherroub R
Colloids Surf B Biointerfaces; 2015 Nov; 135():441-447. PubMed ID: 26280818
[TBL] [Abstract][Full Text] [Related]
20. Lipid nanocapsules maintain full integrity after crossing a human intestinal epithelium model.
Roger E; Gimel JC; Bensley C; Klymchenko AS; Benoit JP
J Control Release; 2017 May; 253():11-18. PubMed ID: 28274740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
